Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

Home

Welcome to the Multiple Sclerosis Discovery Forum

An online community and information portal that aims to inspire connections and clinical advances
 

 

 

Become a Member

News & Future Directions

New Findings | 29 Oct 2014

New iPad App Tracks MS Patient Course

Researchers at the University of California, San Francisco, have developed a new tool that allows clinicians to track an individual’s disease course over time and compare it to a core data set of other MS patients. The tool is currently in beta-testing at UCSF.

Pierre-Antoine Gourraud, Ph.D., of the University of California, San Francisco, and I huddled around his iPad and...
News Briefs | 28 Oct 2014

MS Research Roundup: October 28, 2014

Rare Brain Disease Death Reported for Dimethyl Fumarate; Using Arms and Legs After Spinal Cord Injury; How to Sell Bogus Drugs

Items of interest to multiple sclerosis researchers from around the Web...
News Briefs | 21 Oct 2014

No Causal Link Found Between Vaccines and MS

A large case-control study showed no causal link between current vaccines and the risk of MS or other CNS demyelinating disease, but there was a short-term increased risk in younger patients

A large nested case-control study, published October 20 in JAMA Neurology, showed no...

Research Resources

Tools that will help investigators conceive and perform experimental work:

  • The Data Visualization section presents MS-related data in new ways, making it easy for viewers to discover unexpected relationships
    Our latest visualization shows a series of radar plots detailing the baseline characteristics of patients in 74 clinical trials reported between 1993 and 2014 on relapsing-remitting MS and clinically isolated syndrome.

  • Drug-Development Pipeline consolidates key information about compounds under investigation for therapeutic use
    We've added one new trial, updated information on two other trials, and added 11 other pieces of information. The drugs with important additions and changes are dalfampridine, dimethyl fumarate, fingolimod, interferon β-1a, interferon β-1b, mitoxantrone, natalizumab, and teriflunomide.
    We've also added a new entry for ATX-MS-1467, which contains information on three trials as well as 23 other pieces of information.
  • Tissue Repositories lists features of the world's tissue repositories and brain banks, including rules of engagement and contact information
  • MSGene provides a comprehensive, unbiased and regularly updated collection of genetic association studies performed on multiple sclerosis phenotypes
  • Animal Models summarizes the promises and pitfalls of animal models used in MS research
    We've added a detailed review of zebrafish as a model organism in MS research.

  • Clinical Trials lists sources of information about MS clinical trials

Professional Resources

Forums

Discussions | 22 Oct 2013

Evoked potential test

 
Hi
I'm interested in everything related to Evoked Potential  testing

Recent Comments

New Findings | 29 Oct 2014
Thank you for this vibrant article , Cynthia....
Discussions | 27 Oct 2014
Interesting idea about vitamin D. But is there...
Discussions | 27 Oct 2014
Could it not be caused by higher vitamin D levels?

MSDF Tweets

NYAS T Cell Meeting

In the News
Read Science Translational Medicine's article about MS Discovery Forum